RSS | Login | Register

LEXAPRO

Compare to Similar Drugs | Add to Clipboard | View Clipboard | Print | Email

Close [X]

Compare LEXAPRO to:

Generic Name for LEXAPRO

Escitalopram (as oxalate) (single-isomer citalopram) 5mg, 10mg+, 20mg+; tabs (+scored).

Legal Classification:

Pharmacological Class for LEXAPRO

SSRI.

Manufacturer of LEXAPRO

Forest Laboratories

Indications for LEXAPRO

Generalized anxiety disorder.

Adult dose for LEXAPRO

Initially 10mg once daily; may increase to 20mg once daily after 1 week. Elderly or hepatic impairment: 10mg once daily.

Children's dosing for LEXAPRO

Not recommended.

Also:

LEXAPRO ORAL SOLUTION

Contraindications for LEXAPRO

Concomitant pimozide. During or within 14 days of MAOIs; do not start an MAOI during or within 14 days of escitalopram.

Warnings/Precautions for LEXAPRO

History of seizures or mania/hypomania. Monitor for serotonin syndrome or neuroleptic malignant syndrome-like symptoms; discontinue if occurs. Hepatic or severe renal impairment (CrCl <20mL/min). Conditions that affect metabolic or hemodynamic responses. Recent MI. Unstable heart disease. Suicidal tendencies (monitor). ECT. Avoid abrupt cessation. Reevaluate periodically. Write ℞ for smallest practical amount. Labor & delivery. Pregnancy (Cat.C) (avoid 3^rd trimester; see literature for effects on neonate). Nursing mothers: not recommended.

Interactions for LEXAPRO

MAOIs: see Contraindications. Do not give with citalopram. Concomitant SSRIs, SNRIs, tryptophan: not recommended. Avoid alcohol. Caution with drugs that affect coagulation (eg, warfarin, aspirin, NSAIDs). May be antagonized by carbamazepine. Caution with drugs metabolized by CYP2D6 or other centrally-acting drugs. Increases metoprolol levels. Caution with triptans, linezolid, lithium, tramadol, or St. John's wort; may cause serotonin syndrome (eg, agitation, tachycardia, incoordination, hyperreflexia).

Adverse Reactions for LEXAPRO

Nausea, insomnia, somnolence, ejaculation disorder, fatigue, increased sweating, sexual dysfunction, decreased libido, anorgasmia, decreased appetite, hyponatremia, abnormal bleeding, dizziness, neuroleptic malignant syndrome; others.

How is LEXAPRO supplied?

Tabs—100
Soln—240mL

Related Disease:

Anxiety

CDC issues statement and recommendations regarding prescription drug misuse

June 04, 2010

The CDC announced the 2009 National Youth Risk Behavior Survey (YRBS) found that 1 in 5 high school students have ever taken a prescription drug such as OxyContin (oxycodone, from Purdue), Percocet (oxycodone/acetaminophen, from Endo), Vicodin (hydrocodone/acetaminophen, from Abbott), Adderall (mixed salts of a single-entity amphetamine product, from Shire), Ritalin (methylphenidate, from Novartis), or Xanax (alprazolam, from Pfizer), without a prescription.

FDA launches "Bad Ad Program" to detect misleading drug ads

May 11, 2010

The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.

Exel/Exelint infusion set needles recalled

January 26, 2010

FDA notified healthcare professionals of a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets, and Exel/Exelint "Securetouch+" Safety Huber Infusion Sets due to 'coring,' the cutting or dislodging of silicone cores or slivers from the ports into which they are inserted).

Cymbalta approved for maintenance treatment of generalized anxiety disorder (GAD)

November 30, 2009

The FDA has approved Cymbalta (duloxetine HCl, from Lilly) for the maintenance treatment of generalized anxiety disorder (GAD) in adults.

Once-daily venlafaxine extended-release tablets available

August 19, 2009

Osmotica Pharmaceutical and Upstate Pharma, a subsidiary of UCB, have made available venlafaxine extended-release tablets in 37.5mg, 75mg, 150mg, and 225mg dosage strengths.